Advertisement

Intensive Care Medicine

, Volume 42, Issue 5, pp 797–799 | Cite as

Biomarkers of ARDS: what’s new?

  • Lorraine B. WareEmail author
  • Carolyn S. Calfee
What's New in Intensive Care

Despite hundreds of studies of biomarkers in the acute respiratory distress syndrome (ARDS), there are no biomarkers of ARDS in use in clinical practice [1]. A recent meta-analysis highlights some of the limitations of current studies: small sample sizes, inadequate and inconsistent controls, and lack of large validation studies for many biomarkers [2]. Nevertheless, recent progress in several areas of biomarker research, including advances in the development of point-of-care testing technologies, has the potential to transform the application of biomarkers to clinical ARDS and may soon lead to the use of biomarkers at the bedside for diagnosis, risk stratification, and molecular phenotyping.

One area where there has been significant progress is in the identification of biomarkers with greater specificity for ARDS. Studies of single candidate biomarkers have yet to yield a troponin-like biomarker specific for lung injury that could be used clinically for diagnosis, severity assessment,...

Keywords

Acute Lung Injury Acute Respiratory Distress Syndrome Latent Class Analysis Acute Respiratory Distress Syndrome Patient Alveolar Fluid Clearance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with ethical standards

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

References

  1. 1.
    Janz DR, Ware LB (2013) Biomarkers of ALI/ARDS: pathogenesis, discovery, and relevance to clinical trials. Semin Respir Crit Care Med 34(4):537–548CrossRefPubMedGoogle Scholar
  2. 2.
    Terpstra ML, Aman J, van Nieuw Amerongen GP, Groeneveld AB (2014) Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 42(3):691–700CrossRefPubMedGoogle Scholar
  3. 3.
    Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K et al (2006) Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173(9):1008–1015CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Jabaudon M, Blondonnet R, Roszyk L, Bouvier D, Audard J, Clairefond G et al (2015) Soluble RAGE predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am J Respir Crit Care Med. doi: 10.1164/rccm.201501-0020OC
  5. 5.
    Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N et al (2008) Plasma receptor for advanced glycation end-products and clinical outcomes in acute lung injury. Thorax 63:1083–1089CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT et al (2010) Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137(2):288–296CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Fremont RD, Koyama T, Calfee CS, Wu W, Dossett LA, Bossert FR et al (2010) Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma 68(5):1121–1127CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Brown RM, Semler MW, Zhao Z, Koyama T, Janz DR, May AK et al (2015) Plasma angiopoietin-2 (Ang2) and receptor for advanced glycation end products (RAGE) improve diagnosis of ARDS compared to provider clinical assessment in adult trauma patients. Am J Respir Crit Care Med 191:A4417Google Scholar
  9. 9.
    Ware LB, Koyama T, Zhao Z, Janz DR, Wickersham N, Bernard GR et al (2013) Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care 17(5):R253CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Schnapp LM, Donohoe S, Chen J, Sunde DA, Kelly PM, Ruzinski J et al (2006) Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol 169(1):86–95CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Rogers AJ, Matthay MA (2014) Applying metabolomics to uncover novel biology in ARDS. Am J Physiol Lung Cell Mol Physiol 306(11):L957–L961CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Gerszten RE, Accurso F, Bernard GR, Caprioli RM, Klee EW, Klee GG et al (2008) Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI clinical proteomics programs. Am J Physiol Lung Cell Mol Physiol 295(1):L16–L22CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    McVey M, Tabuchi A, Kuebler WM (2012) Microparticles and acute lung injury. Am J Physiol Lung Cell Mol Physiol 303(5):L364–L381CrossRefPubMedGoogle Scholar
  14. 14.
    Matthay MA, Ware LB, Zimmerman GA (2012) The acute respiratory distress syndrome. J Clin Investig 122(8):2731–2740CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA et al (2015) Distinct molecular phenotypes of direct vs indirect ards in single-center and multicenter studies. Chest 147(6):1539–1548CrossRefPubMedGoogle Scholar
  16. 16.
    Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L et al (2012) The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 18(8):1217–1223CrossRefPubMedGoogle Scholar
  17. 17.
    Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351(4):327–336CrossRefPubMedGoogle Scholar
  18. 18.
    Wong HR, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N et al (2011) Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med 39(11):2511–2517CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg and ESICM 2015

Authors and Affiliations

  1. 1.Department of Medicine and Pathology, Microbiology and ImmunologyVanderbilt University School of MedicineNashvilleUSA
  2. 2.Department of Medicine and AnesthesiaUniversity of California, San FranciscoSan FranciscoUSA
  3. 3.Allergy, Pulmonary and Critical Care MedicineVanderbilt University School of MedicineNashvilleUSA

Personalised recommendations